VCS-15629-58365
4 vaccinations
0 coded responses
17 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 956 / CA
- Registered
- 2022-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-26
Dose 1 — Pfizer-BioNTech
-
2021-09-16
Dose 2 — Pfizer-BioNTech
-
2022-02-22
Registered in v-safe
-
2022-02-22
Dose 3 — Pfizer-BioNTech
- 2022-02-22
- 2022-02-23
- 2022-02-24
-
2022-02-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-02-26
- 2022-02-27
- 2022-02-28
- 2022-03-01
- 2022-03-08
- 2022-03-15
- 2022-03-22
- 2022-03-29
- 2022-04-05
- 2022-08-23
-
2022-11-30
Dose 4 — Pfizer-BioNTech
- 2023-02-22
- 2023-03-01
- 2023-05-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-26 | Pfizer-BioNTech | No |
| 2 | 2021-09-16 | Pfizer-BioNTech | No |
| 3 | 2022-02-22 | Pfizer-BioNTech | No |
| 4 | 2022-11-30 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.